Get the Stockscreener App
92.08
5.63%
4.91
After Hours:
92.08
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich (NASDAQ:WGS) - Seeking Alpha
GeneDx CEO Katherine Stueland sells $258,695 in company stock By Investing.com - Investing.com South Africa
GeneDx CEO Katherine Stueland sells $258,695 in company stock - Investing.com
Genedx CFO Kevin Feeley sells shares worth $87k - Investing.com India
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? - Insider Monkey
10 Best Emerging Technology Stocks to Buy Now - Insider Monkey
Lisanti Capital Growth LLC Raises Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics By Investing.com - Investing.com South Africa
GeneDx at TD Cowen Conference: Strategic Expansion in Genomics - Investing.com India
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Principal Financial Group Inc. - Defense World
Rhumbline Advisers Buys 1,021 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Shares Surge Amid Strong Prospects - TipRanks
GeneDx Expanding Genetic Testing to Include Cerebral Palsy -March 04, 2025 at 09:53 am EST - Marketscreener.com
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Sees Significant Increase in Short Interest - Defense World
GeneDx Holdings Corp. (NASDAQ:WGSWW) Short Interest Update - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings CorpWGS - PR Newswire
An Investigation Has Commenced on Behalf of GeneDx Holdings Corp. Shareholders. Contact Levi & Korsinsky to Discuss your WGS Losses. - ACCESS Newswire
GeneDx Holdings Corp. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsWGS - ACCESS Newswire
New York State Common Retirement Fund Buys 52,843 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Why Investors Shouldn't Be Surprised By GeneDx Holdings Corp.'s (NASDAQ:WGS) 32% Share Price Surge - Simply Wall St
GeneDx Holdings Corp (NASDAQ: WGS) 0.89% Incline Turns Investors Away - Stocks Register
GeneDx Holdings Stock Soars on Strong Earnings - TipRanks
GeneDx Holdings Corp.: A Comprehensive Analysis - HPBL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect - Markets Insider
Head-To-Head Review: Vsee Health (NASDAQ:VSEE) versus GeneDx (NASDAQ:WGS) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
GeneDx (NASDAQ:WGS) Shares Down 6.3%Time to Sell? - MarketBeat
GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know - MSN
GeneDx Highlights Strong Growth in Earnings Call - TipRanks
GeneDx (NASDAQ:WGS) Announces Earnings Results, Beats Estimates By $0.66 EPS - MarketBeat
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Learn to Evaluate (WGS) using the Charts - Stock Traders Daily
The Goldman Sachs Group Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - Defense World
GeneDx (NASDAQ:WGS) Hits New 52-Week High on Better-Than-Expected Earnings - Armenian Reporter
Allspring Global Investments Holdings LLC Has $7.18 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
GeneDx Holdings Corp. SEC 10-K Report - TradingView
A Closer Look at GeneDx Hldgs's Options Market Dynamics - Benzinga
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - Markets Insider
Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' - Seeking Alpha
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - Insider Monkey
GeneDx price target raised to $135 from $118 at TD Cowen - TipRanks
3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2% - Simply Wall St
GeneDx (NASDAQ:WGS) Hits New 52-Week High After Better-Than-Expected Earnings - Defense World
GeneDx Holdings Corp (WGS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
GeneDx Reports Strong 2024 Growth and 2025 Outlook - TipRanks
GeneDx Stock Was up 2,700% in 2024 — Can It Keep Rising? - Investing.com
GeneDx Holdings Corp: A Stock on the Rise - RagingBull
Craig Hallum Raises GeneDx Holdings' Price Target to $114 From $95, Keeps Buy Rating - Marketscreener.com
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday - Benzinga
GeneDx targets $350M-$360M revenue for 2025 with 30% growth in exome and genome testing - MSN
Earnings call transcript: GeneDx Q4 2024 beats forecasts, stock surges - Investing.com
3.20%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):